PIGZ | Phosphatidylinositol glycan anchor biosynthesis, class Z | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
PIRT | Phosphoinositide-interacting regulator of transient receptor potential channels | Predicted membrane proteins
| | | | | Tissue enhanced |
PKIB | Protein kinase (cAMP-dependent, catalytic) inhibitor beta | Predicted intracellular proteins
| | | | | Tissue enhanced |
PLA2G10 | Phospholipase A2, group X | Enzymes Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
PPP1R14D | Protein phosphatase 1, regulatory (inhibitor) subunit 14D | Predicted intracellular proteins
| | | | | Tissue enhanced |
PPP1R1B | Protein phosphatase 1, regulatory (inhibitor) subunit 1B | Predicted intracellular proteins
| | | | | Tissue enhanced |
PTGDR | Prostaglandin D2 receptor (DP) | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
PTPRO | Protein tyrosine phosphatase, receptor type, O | Cancer-related genes Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
REP15 | RAB15 effector protein | Predicted intracellular proteins
| | | | | Tissue enhanced |
RETNLB | Resistin like beta | Predicted secreted proteins
| | | | | Tissue enhanced |
RXFP4 | Relaxin/insulin-like family peptide receptor 4 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
SAMD13 | Sterile alpha motif domain containing 13 | Predicted intracellular proteins
| | | | | Tissue enhanced |
SCGN | Secretagogin, EF-hand calcium binding protein | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
SEMA4G | Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
SLC17A4 | Solute carrier family 17, member 4 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC28A2 | Solute carrier family 28 (concentrative nucleoside transporter), member 2 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC6A7 | Solute carrier family 6 (neurotransmitter transporter), member 7 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC9A2 | Solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
TFF3 | Trefoil factor 3 (intestinal) | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRABD2A | TraB domain containing 2A | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
TRIM31 | Tripartite motif containing 31 | Predicted intracellular proteins
| | | | | Tissue enhanced |
TSPAN1 | Tetraspanin 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
TSPAN8 | Tetraspanin 8 | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
WNK4 | WNK lysine deficient protein kinase 4 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
ZG16 | Zymogen granule protein 16 | Predicted secreted proteins
| | | | | Tissue enhanced |
ZNF321P | Zinc finger protein 321, pseudogene | Predicted intracellular proteins
| | | | | Tissue enhanced |
ZNF695 | Zinc finger protein 695 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |